UCSF assistant professor to receive the 2025 Dr. Nanette K. Wenger Research Goes Red® Award

Dr. Megan McLaughlin to be honored at American Heart Association Scientific Sessions 2025

2025-09-29

(Press-News.org) DALLAS, Sept 29, 2025 — Megan McLaughlin, M.D., M.P.H., an assistant professor of medicine in the division of cardiology at University of California, San Francisco (UCSF), has been selected to receive the 2025 Dr. Nanette K. Wenger Research Goes Red® Award at the American Heart Association’s Scientific Sessions 2025. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. The award will be presented to Dr. McLaughlin during the annual Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women session at 1:30 p.m. CT, Saturday, Nov. 8.

The Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women is named in honor of Nanette K. Wenger, M.D., FAHA, and her pioneering career in women’s cardiovascular disease medicine. Dr. Wenger is an emeritus professor of medicine in the division of cardiology at Emory University School of Medicine, consultant to the Emory Heart and Vascular Center, founding consultant to the Emory Women’s Heart Center and director of the Cardiac Clinics and Ambulatory Electrocardiographic Laboratory at Grady Memorial Hospital in Atlanta. The Dr. Nanette K. Wenger Award is given annually in recognition of the best research article or articles focused on cardiovascular disease and stroke in women published during the previous year in any of the Association’s 14 peer-reviewed, scientific journals. The Association’s Research Goes Red® initiative aims to empower women to contribute to health research.

Dr. McLaughlin was selected for this year’s award for her article, “Disparities in Postpartum Care After a Hypertensive Disorder of Pregnancy in the United States,” published in the Association’s journal Hypertension on April 2, 2025. Her research highlighted critical gaps in postpartum care for individuals with hypertensive disorders of pregnancy, a major risk factor for future cardiovascular disease. Using nationally representative data from over 47,000 postpartum individuals with hypertensive disorders of pregnancy, Dr. McLaughlin and co-authors found that while most patients attended a postpartum visit, attending postpartum visits varied by race, ethnicity, insurance status and socioeconomic factors. In addition, many patients reported not receiving essential counseling or screening for cardiovascular risk factors, such as lifestyle guidance, smoking cessation or diabetes testing in their postpartum visit. The study confirms missed opportunities to improve long-term heart health in a high-risk population.

“Dr. McLaughlin’s research on cardiovascular disease in women, particularly among high-risk populations, underscores the critical role of early education and targeted intervention in preventing long-term heart disease,” said Stacey E. Rosen, M.D., FAHA, the American Heart Association’s 2025-2026 volunteer president, executive director for Northwell’s Katz Institute for Women’s Health, senior vice president of Women’s Health at Northwell, the Partners Council Professor of Women’s Health and professor of cardiology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. “A greater focus on women’s health, especially during pregnancy, helps ensure that women with higher risk receive the tools, knowledge and support they need to manage their heart health effectively. This study provides important, meaningful and impactful information that can help us to improve postpartum care and help more women live longer, healthier lives.”

Submissions for the 2025 Dr. Nanette K. Wenger Research Goes Red for Women Award were evaluated by 25 expert peer reviewers for their scientific impact, innovation, methodology, and quality of data and evidence supporting hypotheses and conclusions. Dr. McLaughlin’s manuscript was selected out of 123 submissions from 17 different countries published in the Association’s scientific journals between June 1, 2024, and May 29, 2025.

“I have been such an admirer of Dr. Nanette Wenger’s trailblazing career. And I’m deeply honored to receive this recognition from the American Heart Association on behalf of my co-authors,” said Dr. McLaughlin. “As a woman and a clinician, I’m passionate about pursuing research that leads to better cardiovascular care for women.”

Dr. McLaughlin is a cardiologist with advanced training in echocardiography (ultrasound of the heart). She is particularly interested in heart disease prevention and women's cardiovascular health. In her research, McLaughlin develops and evaluates new approaches to heart disease prevention, with a focus on improving the management of risk factors such as high blood pressure. She also studies how to keep women with pregnancy complications from developing heart disease.

Dr. McLaughlin has been recognized by the Association and others for her leadership and contributions to cardiovascular research and public health. A recipient of the 2023 American Heart Association Get With the Guidelines® Early Career Investigator Database Research Seed Grant, she was also awarded Second Prize in the 2023 American Heart Association Research Goes Red Data Challenge and named a 2023 World Heart Federation Emerging Leader. Dr. McLaughlin has received numerous other honors, including a Fulbright Scholarship, the Charles Janeway Prize for International Research from Harvard Medical School and recognition as a Laennec Fellow in Training Clinician Award Finalist by the American Heart Association. In addition to her academic and research achievements, Dr. McLaughlin serves on several leadership committees, including the Heart Association’s Council on Epidemiology and Prevention’s Social Determinants of Health Committee and the American College of Cardiology’s Prevention of Cardiovascular Disease Section Leadership Council.

Dr. McLaughlin earned her medical degree from Harvard Medical School and a master of public health degree from Yale School of Public Health. She completed her medical training at UCSF with a residency in internal medicine, a fellowship in cardiology and a fellowship in advanced echocardiography.

Additional Resources:

Multimedia is available on the right column of the release link. For more news at American Heart Association Scientific Sessions 2025, follow us on X @HeartNews, #AHA25 ###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

END

ELSE PRESS RELEASES FROM THIS DATE:

Steel making could get a makeover

2025-09-29

Researchers investigate clean and efficient new method for iron production MINNEAPOLIS / ST. PAUL (09/29/2025) — A research team at the University of Minnesota Twin Cities has investigated a new method to produce iron, the main component of steel. For the first time, the researchers were able to observe chemical reactions and iron formation in real-time at the nanometer scale. This breakthrough has the potential to transform the global iron and steel production industry by improving energy efficiency ...

TTUHSC researchers find blood-brain barrier remains resilient in Alzheimer’s disease model

2025-09-29

A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the brain’s protective shield — known as the blood-brain barrier (BBB) — remains largely intact in a commonly used mouse model of Alzheimer’s disease. The discovery challenges long-standing assumptions that Alzheimer’s disease causes the BBB to “leak,” potentially reshaping how researchers think about drug delivery for the disease. The study, published July 23 in Fluids and Barriers of the CNS, was conducted by a research team ...

Scalable and efficient quantum error correction for fault-tolerant quantum computing

2025-09-29

A new class of highly efficient and scalable quantum low-density parity-check error correction codes, capable of performance approaching the theoretical hashing bound, has been developed by scientists at Institute of Science Tokyo, Japan. These novel error-correction codes can handle quantum codes with hundreds of thousands of qubits, potentially enabling large-scale fault-tolerant quantum computing, with applications in diverse fields, including quantum chemistry and optimization problems. In recent years, quantum computers have begun to handle double-digit quantum bits, or qubits. However, many essential applications targeted by quantum computers, such as quantum chemistry, ...

Japan’s national standardized health checkup program: impacts on self-employed and unemployed populations

2025-09-29

Rapidly aging populations and rising cases of lifestyle-related diseases (LRDs), like diabetes and hypertension, are driving significant financial strain on government budgets. While regular health checkups under a standardized government program can be a solution, it is not well understood how these initiatives benefit different socioeconomic sections of the society and their economic feasibility. Most studies have documented how health checkup programs affect salaried or employed workers, examining the program’s role in informing individuals about their health status and risks. However, ...

APSS accepting sleep and circadian research abstracts and session proposals for SLEEP 2026 in Baltimore

2025-09-29

DARIEN, IL – The Associated Professional Sleep Societies is accepting research abstracts and session proposal submissions for SLEEP 2026, the 40th annual meeting of the APSS, which will be held June 14 to 17 at the Baltimore Convention Center. Research abstracts will be accepted for oral and poster presentations in two tracks: basic and translational sleep and circadian science and clinical sleep science and practice. Accepted abstracts will be published online in a supplement of the journal Sleep. The APSS Program Committee is also accepting proposals for postgraduate courses and other sessions including bench-to-bedside sessions, clinical workshops, discussion ...

Startling images show how antibiotic pierces bacteria’s armor

2025-09-29

A team led by UCL (University College London) and Imperial College London researchers has shown for the first time how life-saving antibiotics called polymyxins pierce the armour of harmful bacteria. The findings, published in the journal Nature Microbiology, could lead to new treatments for bacterial infections – especially urgent since drug-resistant infections already kill more than a million people a year. Polymyxins were discovered more than 80 years ago and are used as a last-resort treatment for infections caused ...

Patients with intellectual and developmental disabilities substantially over-represented among long-stay psychiatric inpatients

2025-09-29

Toronto, ON, September 29, 2025 – Individuals with intellectual and developmental disabilities (IDD) account for more than one in five patients who have been in Ontario’s mental health beds for over a year, according to a new study from researchers at ICES and the Centre for Addiction and Mental Health (CAMH). The findings suggest that people with IDD have different support needs compared with patients without IDD as they are more likely to have moderate or severe cognitive impairment, difficulty caring for themselves, and few social supports, which may contribute to challenges transitioning out of hospital and into the community. Enhancing specialized ...

AI distinguishes glioblastoma from look-alike cancers during surgery

2025-09-29

At a glance: Correctly distinguishing between look-alike tumors found in the brain during surgery can guide critical decisions in real time while patient is still in the operating room. A new AI tool outperformed humans and other models in distinguishing glioblastoma from another type of cancer that appears similar under a microscope. The new AI tool has a built-in uncertainty feature that flags tumors the model has not encountered before and marks them for human review. A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the ...

Many older adults – especially Gen X women – show signs of addiction to ultra-processed foods

2025-09-29

They were the first generation of Americans to grow up with ultra-processed foods all around them – products typically loaded with extra fat, salt, sugar and flavorings. They were children and young adults at a time when such products, designed to maximize their appeal, proliferated. Now, a study shows, 21% of women and 10% of men in Generation X and the tail end of the Baby Boom generation, now in their 50s and early 60s, meet criteria for addiction to these ultra-processed foods. That rate is far higher than it is among ...

Simple test can predict risk of severe liver disease

2025-09-29

A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can predict the risk of developing severe liver disease. The method may already start to be applied in primary care to enable the earlier detection of cirrhosis and cancer of the liver. “These are diseases that are growing increasingly common and that have a poor prognosis if detected late,” says Rickard Strandberg, affiliated researcher at Karolinska Institutet’s Department of Medicine in ...